Treace Medical Concepts (TMCI) Osake Kurssi
Treace Medical Concepts Kurssi
Liikevaihto on kasvanut 32,4 % vuodessa viimeisten 6 vuoden aikana 207,37 M USD:een. Treace Medical Conceptsn nettomarginaali on nyt −28,5 %, laskenut −22,7 %:sta muutama vuosi sitten. Analyytikoiden mediaanitavoitehinta on 6,50 USD, eli yli nykyhintaa 55,9 %. 10 analyytikosta 1 suosittaa ostoa — kokonaiskonsensus on Pidä.
Treace Medical Concepts osakekurssi
Hae nämä tiedot Eulerpool API:n kautta
100 000 pyyntöä/kk ilmaiseksi · ei luottokorttia
Treace Medical Concepts liiketoimintamalli ja osakeanalyysi
Usein kysytyt kysymykset Treace Medical Concepts -osakkeesta
Treace Medical Concepts Inc operates with a business model focused on orthopedic medical devices. As a company, they specialize in developing and commercializing innovations for foot and ankle surgical procedures. Treace Medical Concepts Inc aims to provide advanced treatment solutions through their portfolio of products. With a focus on improving patient outcomes and surgeon experience, the company strives to address the unmet needs of the foot and ankle surgical market. Through their dedication to developing specialized medical devices, Treace Medical Concepts Inc continues to contribute to the advancement of orthopedic care.
Treace Medical Concepts Inc is primarily active in the healthcare and medical industry.
The main competitors of Treace Medical Concepts Inc in the market include renowned medical device companies such as Stryker Corporation, Wright Medical Group N.V., and Zimmer Biomet Holdings Inc.
Treace Medical Concepts Inc is a renowned medical device company specializing in foot and ankle surgical procedures. Established in 2014, the company has rapidly gained recognition for its innovative products and surgical techniques, offering advanced solutions to address various foot and ankle conditions. Treace Medical Concepts Inc has revolutionized treatment with its flagship product, Lapiplasty® 3D Bunion Correction™ System, which provides a more effective and lasting solution compared to traditional bunion surgeries. With a commitment to improving patient outcomes and advancing foot and ankle care, Treace Medical Concepts Inc continues to lead the way in the field of orthopedic medicine.
Treace Medical Concepts Inc. has achieved noteworthy milestones since its inception. With a strong focus on surgical solutions for foot and ankle conditions, the company has been successful in revolutionizing the orthopedic industry. Treace Medical Concepts Inc.'s most significant milestone came with the development and introduction of the patented Lapiplasty® 3D Bunion Correction™ System. This innovative system provides a reliable and reproducible surgical solution for bunion deformities, addressing the root cause and providing lasting relief to patients. The company's commitment to innovation and advancement in foot and ankle surgery has positioned Treace Medical Concepts Inc. as a leader in the industry, delivering improved patient outcomes and transforming the standard of care.
Treace Medical Concepts Inc is primarily present in the United States.
Treace Medical Concepts Inc is a renowned medical company that upholds strong values and a robust corporate philosophy. The company is committed to delivering innovative and comprehensive solutions for foot and ankle healthcare. With a steadfast focus on patient-centered care, Treace Medical Concepts Inc strives to improve the quality of life for individuals suffering from various foot conditions. Their dedication to research, development, and exceptional quality standards enables them to provide effective treatments and surgical solutions. With a focus on continuous improvement and excellence, Treace Medical Concepts Inc sets the benchmark for superior foot and ankle healthcare in the industry.
Analyytikot asettavat tällä hetkellä Treace Medical Concepts-osakkeelle keskimääräisen tavoitehinnan 8,60 USD (mediaani: 6,50 USD), mikä merkitsee +106,2 % viimeisimpään hintaan verrattuna. Konsensus perustuu 10 analyytikkoarvioon.
10 analyytikkoa arvioi tällä hetkellä Treace Medical Concepts-osaketta: 1 suosittaa ostoa, 5 pitoa ja 4 myyntiä. Vuodelle 2026 analyytikot odottavat Treace Medical Concepts-yhtiöltä 207,56 M USD liikevaihtoa ja −0,85 USD osakekohtaista tulosta.
Nykyisellä valuuttakurssilla Treace Medical Concepts-osake noteerataan hintaan 3,71 EUR (4,17 USD).
Treace Medical Concepts-osake (TMCI) on listattuna 1 pörssissä, muun muassa: NASDAQ (TMCI).
Treace Medical Concepts Inc is a company specializing in the development, manufacturing, and sale of innovative medical devices for orthopedics and foot surgery. The company is headquartered in Ponte Vedra Beach, Florida and was founded in 2014 by an experienced team of physicians and entrepreneurs. The company has various departments, including innovation, sales, information, and marketing. The innovation department conducts research and development projects to develop groundbreaking technologies for use in the orthopedic and foot surgery industry. One of the company's most well-known product lines is the Lapiplasty® procedures, used for correcting hallux valgus. The unique Lapiplasty® procedure not only corrects the alignment of the big toe but also correctly aligns the three important joint angles. This leads to better long-term stability and prevention of relapses. The Lapiplasty® system is the only system that allows for complete three-dimensional correction and enables a quick return to wearing regular shoes. The company also offers a range of other products, including the Fastgraft® Meniscal Viable Repair System, which allows for minimally invasive arthroscopic repair of the meniscus, and the Zip® system, a device for minimally invasive pain reduction in foot procedures. The company's sales department works closely with customers and facilities to ensure that the products can be used quickly and effectively. The information department provides training materials and educational formats, ensuring smooth integration and handling of the products. The company's marketing department is responsible for presenting the company and its products and positioning itself in the market. This involves attending various industry events such as medical technology fairs and conferences to promote the company's products and maintain contacts with potential customers. Treace Medical Concepts Inc's business model is based on close collaboration with the users of its products. Feedback from physicians, nurses, and patients is incorporated into the ongoing development of the products and business strategy. The company continuously strives to advance and enable groundbreaking innovations in the field of orthopedics and foot surgery and improve surgical procedures and methods. In summary, Treace Medical Concepts Inc is an innovative company in the medical technology industry specializing in the development of new technologies to improve orthopedics and foot surgery. Collaboration with users, the development of training programs, effective sales management, and product marketing are key pillars of the business strategy.
odotettu liikevaihto Treace Medical Concepts on 207,56 M USD. Tämä luku perustuu nykyisiin talousarvoihin ja heijastaa yhtiön liiketoimintasuoritusta.
odotettu voitto Treace Medical Concepts on −54,16 M USD. Nettovoitto kuvastaa yhtiön kannattavuutta kaikkien kulujen vähentämisen jälkeen.
Treace Medical Concepts:n hinta-voitto-suhde (P/E) on tällä hetkellä −4,92. P/E-suhde vertaa nykyistä osakekurssia osakekohtaiseen tulokseen ja auttaa sijoittajia arvioimaan Treace Medical Concepts-osakkeen arvostusta.
Treace Medical Concepts:n hinta-myynti-suhde (P/S) on tällä hetkellä 1,28. P/S-suhde vertaa markkina-arvoa vuosittaisiin tuloihin ja toimii Treace Medical Concepts-osakkeen arvostuskennuslukuna.
Treace Medical Concepts:n Eulpool-laatuscore on 4/10.
Treace Medical Concepts:n ISIN on US89455T1097. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.
Treace Medical Concepts:n ticker on TMCI. Tämä pörssinoteeraus käytetään Treace Medical Concepts-osakkeiden kauppaan pörssissä.
Treace Medical Concepts osake
Treace Medical Concepts vertaisryhmä
Treace Medical Concepts Ticker
Treace Medical Concepts FIGI
Kaikki tunnusluvut ja syvällinen analyysi Treace Medical Concepts:sta
Meidän osakeanalyysimme Treace Medical Concepts-osakkeesta sisältää tärkeitä taloudellisia tunnuslukuja, kuten liikevaihdon, voiton, P/E-luvun, P/S-luvun, EBIT:n sekä tietoja osingosta. Lisäksi tarkastelemme asioita kuten osakkeet, markkina-arvo, velat, oma pääoma ja vastuut Treace Medical Concepts:n yhteydessä. Jos etsit yksityiskohtaisempaa tietoa näistä aiheista, tarjoamme alisivuillamme kattavia analyysejä: